Stock Taper
Latest 13F filing data - Q2 2026
| STOCK | TICKER | SHARES HELD▲ ▼ | VALUE▲ ▼ |
|---|---|---|---|
Revolution Medicines, Inc. | RVMD | 700K | $131.1M |
Dianthus Therapeutics, Inc. | DNTH | 800K | $77.98M |
Disc Medicine, Inc. | IRON | 875K | $64M |
Cogent Biosciences, Inc. | COGT | 900K | $34.83M |
CG Oncology Inc. | CGON | 1M | $71.05M |
ArriVent BioPharma, Inc. | AVBP | 1M | $34.74M |
BioNTech SE | BNTX | 1.01M | $94.45M |
Abivax S.A. | ABVX | 1.02M | $136.46M |
Mineralys Therapeutics, Inc. | MLYS | 1.05M | $28.33M |
Jade Biosciences, Inc. | JBIO | 1.13M | $25M |
Summit Therapeutics Inc. | SMMT | 1.35M | $19.67M |
Trevi Therapeutics, Inc. | TRVI | 1.88M | $35.06M |
Celldex Therapeutics, Inc. | CLDX | 2.1M | $78.14M |
Vera Therapeutics, Inc. | VERA | 2.2M | $94.4M |
Editas Medicine, Inc. | EDIT | 2.22M | $7.2M |
COMPASS Pathways plc | CMPS | 2.25M | $31.84M |
Replimune Group, Inc. | REPL | 2.5M | $27.68M |
Dyne Therapeutics, Inc. | DYN | 2.55M | $56.64M |
MoonLake Immunotherapeutics | MLTX | 2.67M | $52.08M |
Tango Therapeutics, Inc. | TNGX | 2.85M | $89.09M |